
Sign up to save your podcasts
Or


Dr Jennifer Crombie from Dana-Farber Cancer Institute, Prof Martin Hutchings from Copenhagen University Hospital, Dr Matthew Lunning from the University of Nebraska Medical Center, Dr Tycel Phillips from City of Hope and moderator Dr Jeremy S Abramson from Massachusetts General Hospital discuss recently updated data on the role of CAR T-cell therapy and bispecific antibodies in the management of diffuse large B-cell, mantle cell and follicular lymphoma. Produced by Research To Practice.
CME information and select publications here.
By Dr. Neil Love4.9
5656 ratings
Dr Jennifer Crombie from Dana-Farber Cancer Institute, Prof Martin Hutchings from Copenhagen University Hospital, Dr Matthew Lunning from the University of Nebraska Medical Center, Dr Tycel Phillips from City of Hope and moderator Dr Jeremy S Abramson from Massachusetts General Hospital discuss recently updated data on the role of CAR T-cell therapy and bispecific antibodies in the management of diffuse large B-cell, mantle cell and follicular lymphoma. Produced by Research To Practice.
CME information and select publications here.

142 Listeners

321 Listeners

499 Listeners

67 Listeners

32 Listeners

75 Listeners

15 Listeners

17 Listeners

13 Listeners

0 Listeners

118 Listeners

58 Listeners

3,360 Listeners

198 Listeners

43 Listeners

22 Listeners

363 Listeners

190 Listeners

41 Listeners

0 Listeners